Optimal Use of Adjuvant Bisphosphonates and Breast Cancer

J Clin Oncol. 2017 Aug 10;35(23):2719-2720. doi: 10.1200/JCO.2017.73.6157. Epub 2017 Jun 27.

Authors

Trevor J Powles¹, Alexander H G Paterson¹, Julie R Gralow¹

Affiliation

¹ Trevor J. Powles, Institute of Cancer Research and Cancer Centre London, London, United Kingdom; Alexander H.G. Paterson, University of Calgary, Calgary, Alberta, Canada; and Julie R. Gralow, University of Washington School of Medicine and Seattle Cancer Care Alliance, Seattle, WA.

PMID: 28654362
DOI: 10.1200/JCO.2017.73.6157

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Neoplasms*
Breast
Breast Neoplasms*
Diphosphonates
Humans
Medical Oncology
Ontario
United States

Substances

Diphosphonates